MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

Search

Cogent Biosciences Inc

Open

40.66 9.68

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

37.35

Max

40.8

Schlüsselkennzahlen

By Trading Economics

Einkommen

-7.4M

-81M

EPS

-0.5

Angestellte

205

EBITDA

-6.8M

-79M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+42.43% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

24. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

3.2B

5.3B

Vorheriger Eröffnungskurs

30.98

Vorheriger Schlusskurs

40.66

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Cogent Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Jan. 2026, 18:44 UTC

Wichtige Markttreiber

Agenus Falls After $141 Million Zydus Deal Closes

15. Jan. 2026, 17:51 UTC

Wichtige Markttreiber

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15. Jan. 2026, 17:25 UTC

Wichtige Markttreiber

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15. Jan. 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. Jan. 2026, 23:48 UTC

Market Talk

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15. Jan. 2026, 23:40 UTC

Market Talk

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15. Jan. 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

15. Jan. 2026, 23:11 UTC

Market Talk

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15. Jan. 2026, 23:01 UTC

Market Talk

New Zealand's Economy Enters An Upswing -- Market Talk

15. Jan. 2026, 22:56 UTC

Market Talk
Ergebnisse

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15. Jan. 2026, 22:51 UTC

Market Talk

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15. Jan. 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15. Jan. 2026, 21:50 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

15. Jan. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Energy & Utilities Roundup: Market Talk

15. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. Jan. 2026, 21:27 UTC

Ergebnisse

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15. Jan. 2026, 21:15 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Global Commodities Roundup: Market Talk

15. Jan. 2026, 21:11 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Global Equities Roundup: Market Talk

15. Jan. 2026, 21:11 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15. Jan. 2026, 20:10 UTC

Market Talk

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15. Jan. 2026, 20:04 UTC

Ergebnisse

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15. Jan. 2026, 20:03 UTC

Market Talk

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15. Jan. 2026, 19:26 UTC

Market Talk

Silver Closes at Fresh High -- Market Talk

15. Jan. 2026, 18:29 UTC

Wichtige Markttreiber

Agenus Falls After $141M Zydus Deal Closes

15. Jan. 2026, 18:20 UTC

Ergebnisse

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15. Jan. 2026, 17:56 UTC

Market Talk
Ergebnisse

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15. Jan. 2026, 17:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Auto & Transport Roundup: Market Talk

15. Jan. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

15. Jan. 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15. Jan. 2026, 17:02 UTC

Akquisitionen, Fusionen, Übernahmen

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Peer-Vergleich

Kursveränderung

Cogent Biosciences Inc Prognose

Kursziel

By TipRanks

42.43% Vorteil

12-Monats-Prognose

Durchschnitt 50.25 USD  42.43%

Hoch 67 USD

Tief 34 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cogent Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

13 ratings

11

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

4.88 / 5.87Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Strong Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
help-icon Live chat